Ibaraki, Japan

Ryo Fujii

This inventor holds 26 USPTO granted patents and 4 EPO patents, primarily in G Protein-Coupled Receptors. Top assignees: Takeda Pharmaceutical Company Limited, Takeda Chemical Industries, Inc., Human Genome Sciences, Inc.. Active years: 1998-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryo Fujii. Retrieved from https://idiyas.com/inventor/ryo-fujii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 46.2


Average Co-Inventor Count = 5.1

ph-index = 4

Forward Citations = 59(Granted Patents)


Location History:

  • Ibaraki, JP (1999 - 2010)
  • Tsukuba, JP (1998 - 2011)
  • Osaka, JP (2010 - 2011)

Company Filing History:


Years Active: 1998-2011

Loading Chart...
Loading Chart...
Areas of Expertise:
G Protein-Coupled Receptors
Screening Method
Polypeptides
Binding Properties
Ligands
Nucleic Acid
Therapeutic Agents
Signal Transduction
Compounds
Prolactin Secretion
DNA Encoding
Human Receptors
26 patents (USPTO):Explore Patents

Title: Ryo Fujii: Pioneering Innovations in Medicine and Healthcare

Introduction

Ryo Fujii, a visionary inventor hailing from Ibaraki, JP, is making waves in the realm of inventions with his relentless pursuit of innovation. With a remarkable portfolio of 26 patents under his belt, Fujii is a trailblazer whose passion for creating a better future through technology sets him apart.

Latest Patents

Among his latest patents is an ingenious Receptor Function Regulating Agent. This groundbreaking agent, designed to regulate receptor function, shows promising potential as a preventive or therapeutic drug for diabetes mellitus, hyperlipidemia, and similar conditions. Comprising a compound with an aromatic ring and a cation-releasing group, this innovation exemplifies Fujii's commitment to advancing healthcare through cutting-edge solutions.

Additionally, Fujii's Screening Method for Binding Property or Signal Transduction Alterations is revolutionizing drug discovery. By utilizing a G protein-coupled receptor protein with a specific amino acid sequence, this method enables the efficient screening of agonists and antagonists essential for developing novel treatments.

Career Highlights

Fujii's journey in the industry has been shaped by his tenure at renowned companies such as Takeda Pharmaceutical Company Limited and Takeda Chemical Industries, Inc. His significant contributions to these organizations have solidified his reputation as a formidable force in the field of pharmaceuticals and healthcare innovation.

Collaborations

Throughout his career, Fujii has collaborated closely with esteemed colleagues such as Shuji Hinuma and Masaki Hosoya. Together, they have synergized their expertise to drive forward groundbreaking research and development initiatives, pushing the boundaries of what is possible in the realm of medical inventions.

Conclusion

In conclusion, Ryo Fujii's pioneering spirit and dedication to innovation have positioned him as a visionary inventor at the forefront of healthcare advancements. With a remarkable track record of patents and a passion for creating impactful solutions, Fujii continues to inspire and shape the future of medicine with his trailblazing inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…